Evidence map›Paper›PMID 33869806›Full record

ArticleJournal of clinical tuberculosis and other mycobacterial diseases2021

Sulfonamides complexed with metals as mycobacterial biofilms inhibitors.

Pauline Cordenonsi Bonez, Vanessa Albertina Agertt, Grazielle Guidolin Rossi, Fallon Dos Santos Siqueira, Josiéli Demétrio Siqueira, Lenice Lorenço Marques, Gelson Noe Manzoni de Oliveira, Roberto Christ Vianna Santos, Marli Matiko Anraku de Campos

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical tuberculosis and other mycobacterial diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 15 citations in OpenAlex.

  1. Microorganisms · 2025
    Review
  2. A laboratory perspective onFrontiers in microbiology · 2024
    Review
  3. Article
  4. Alternatives to Antibiotics againstAntibiotics (Basel, Switzerland) · 2022
    Review
  5. 2-Aminoimidazoles InhibitInternational journal of molecular sciences · 2022
    Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Pauline Cordenonsi BonezPrograma de Pós-graduação em Ciências Farmacêuticas, Universidade Federal de Santa Maria, 1000 Avenida Roraima, 97105900 Santa Maria, RS, Brazil.
Vanessa Albertina AgerttPrograma de Pós-graduação em Ciências Farmacêuticas, Universidade Federal de Santa Maria, 1000 Avenida Roraima, 97105900 Santa Maria, RS, Brazil.
Grazielle Guidolin RossiPrograma de Pós-graduação em Ciências Farmacêuticas, Universidade Federal de Santa Maria, 1000 Avenida Roraima, 97105900 Santa Maria, RS, Brazil.
Fallon Dos Santos SiqueiraPrograma de Pós-graduação em Ciências Farmacêuticas, Universidade Federal de Santa Maria, 1000 Avenida Roraima, 97105900 Santa Maria, RS, Brazil.
Josiéli Demétrio SiqueiraCentro de Ciências Naturais e Exatas, Departamento de Química, Universidade Federal de Santa Maria, 1000 Avenida Roraima, 9710597 Santa Maria, RS, Brazil.
Lenice Lorenço MarquesCentro de Ciências Naturais e Exatas, Departamento de Química, Universidade Federal de Santa Maria, 1000 Avenida Roraima, 9710597 Santa Maria, RS, Brazil.
Gelson Noe Manzoni de OliveiraCentro de Ciências Naturais e Exatas, Departamento de Química, Universidade Federal de Santa Maria, 1000 Avenida Roraima, 9710597 Santa Maria, RS, Brazil.
Roberto Christ Vianna SantosPrograma de Pós-graduação em Ciências Farmacêuticas, Universidade Federal de Santa Maria, 1000 Avenida Roraima, 97105900 Santa Maria, RS, Brazil.
Marli Matiko Anraku de CamposPrograma de Pós-graduação em Ciências Farmacêuticas, Universidade Federal de Santa Maria, 1000 Avenida Roraima, 97105900 Santa Maria, RS, Brazil.
Universidade Federal de Santa Maria · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rapidly growing mycobacteria (RGM) are found in non-sterile water and often associated with severe post-surgical infections and affect immunocompromised patients. In addition, RGM can prevent the host's immune response and have the ability to adhere to and form biofilms on biological and synthetic substrates, making pharmacological treatment difficult because conventional antimicrobials are ineffective against biofilms. Thus, there is an urgent need for new antimicrobial compounds that can overcome these problems. In this context, sulfonamides complexed with Au, Cd, Ag, Cu, and Hg have shown excellent activity against various microorganisms. Considering the importance of combating RGM-associated infections, this study aimed to evaluate the activity of sulfonamide metal complexes against RGM biofilm. The sulfonamides were tested individually for their ability to inhibit mycobacterial formation and destroy the preformed biofilm of standard RGM strains, such as

Indexed as

Biofilmc-di-GMPMetalsRapidly growing mycobacteriaSulfonamides

Identifiers

PMID33869806
PMCPMC8044702
OpenAlexW3122387029

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.